Kopp Family Office, LLC
In its 13F for Q1 2024 (holdings as of March 31, 2024, filed June 17, 2024), Kopp Family Office, LLC reported 21 stock positions worth $175.1 million. Its top holding was Vanguard Ftse Developed ETF (VEA) at 17.7% of the portfolio, followed by iShares Russell 2000 ETF (IWM, 16.4%) and Vericel (VCEL, 13.6%). Compared with Q4 2023, it added to 7 and reduced 3. The biggest buy was Inspire Medical Systems (INSP, shares +24%) and the biggest sale Neogenomics (NEO, shares −0%).
- Most Recent 13F
- Q2 2026
- Location
- MINNETONKA, MN
- CIK
- 0001683689
- Portfolio Value
- $175.1M (Q1 2024)
- SEC Filing
- 0001683689-24-000003 ↗ filed Jun 17, 2024
Holdings Value
Holdings 21 stocks · $175.1M
| VEA Vanguard Ftse Developed ETF | 17.73% | 618,865 | $31.0M | Add +1.1% |
| IWM iShares Russell 2000 ETF | 16.43% | 106,250 | $28.8M | Reduce -6.3% |
| VCEL Vericel Corp. | 13.60% | 457,615 | $23.8M | Reduce -0.4% |
| VWO Vanguard Ftse Emerging Marke | 9.56% | 400,515 | $16.7M | Add +0.8% |
| FIVN FIVE9 Inc. | 8.43% | 237,492 | $14.8M | No change |
| NEO Neogenomics Inc. | 8.03% | 894,509 | $14.1M | Reduce -0.0% |
| TEAM Atlassian Corp. Ltd. Class A | 5.54% | 49,683 | $9.7M | Add +0.0% |
| INSP Inspire Medical Systems Inc. | 5.04% | 41,054 | $8.8M | Add +23.6% |
| JAMF Jamf Holding Corp. filed as JAMF HLDG CORP | 4.22% | 402,451 | $7.4M | No change |
| WK Workiva Inc. | 3.70% | 76,427 | $6.5M | Add +0.1% |
| MODN Model N Inc. | 3.49% | 214,451 | $6.1M | Add +0.1% |
| VRDN Viridian Therapeutics Inc. | 2.06% | 205,640 | $3.6M | Add +0.0% |
| MITK Mitek Systems Inc. | 1.91% | 236,855 | $3.3M | No change |
| IVV iShares Core S&P 500 ETF | 0.06% | 197 | $104K | No change |
| IEFA iShares Core MSCI Eafe ETF | 0.06% | 1,400 | $104K | No change |
| ISTB iShares Core 1-5 Year Usd Bo | 0.05% | 2,015 | $96K | No change |
| IEMG iShares Core MSCI Emerging | 0.03% | 1,150 | $59K | No change |
| IAGG iShares Intl Aggregate Bond | 0.02% | 806 | $40K | No change |
| IMTB iShares Core 5-10 Year Usd | 0.02% | 834 | $36K | No change |
| IJH iShares Core S&P Midcap ETF | 0.02% | 565 | $34K | No change |
| IJR iShares Core S&P Small-Cap E | 0.01% | 164 | $18K | No change |
Portfolio Sells Q4 2023 → Q1 2024
Portfolio Buys Q4 2023 → Q1 2024
| INSP Inspire Medical Systems Inc. | Add +23.6% | 5.04% | +1.09 |
| VEA Vanguard Ftse Developed ETF | Add +1.1% | 17.73% | +0.61 |
| MODN Model N Inc. | Add +0.1% | 3.49% | +0.12 |
| VWO Vanguard Ftse Emerging Marke | Add +0.8% | 9.56% | +0.01 |
| VRDN Viridian Therapeutics Inc. | Add +0.0% | 2.06% | −0.56 |
| WK Workiva Inc. | Add +0.1% | 3.70% | −0.83 |
| TEAM Atlassian Corp. Ltd. Class A | Add +0.0% | 5.54% | −1.36 |
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 29 | $163.2M | AGG, VEA, RSP, SPY, VWO |
| Q1 2026 | 21 | $145.3M | VEA, AGG, RSP, SPY, VWO |
| Q4 2025 | 21 | $156.7M | VEA, RSP, IJH, VWO, AGG |
| Q3 2025 | 26 | $153.6M | VEA, VWO, RSP, IJH, AGG |
| Q2 2025 | 27 | $154.5M | VEA, VWO, RSP, AGG, IJH |
| Q1 2025 | 28 | $144.7M | VEA, VWO, AGG, FIVN, WK |
| Q4 2024 | 21 | $157.8M | VEA, VWO, VCEL, NEO, FIVN |
| Q3 2024 | 22 | $157.0M | VEA, VWO, VCEL, NEO, FIVN |
| Q2 2024 | 21 | $161.2M | VEA, IWM, VCEL, VWO, FIVN |
| Q1 2024 | 21 | $175.1M | VEA, IWM, VCEL, VWO, FIVN |